Taken together, these results indicated that GCN5L1 protein levels decreased in murine HCC cells and tumours, and the regulation of GLS1 and GLS2 needs to be addressed further during the development of HCC. The gene discussed is BLOC1S1; the disease is hepatocellular carcinoma.